MMP2 and COVID-19: Of relevance to the current context, a recent study [67] demonstrated that plasma levels of MMP-2 were increased in hypertensive patients with COVID-19 compared to normotensive patients, although lower than those observed in non-hypertensive patients affected by COVID-19.